Corticosteroids have been commonly used in cycles ... methylprednisolone administration: single doses were found to be effective in blocking headache attacks for several days. A 53 year old man began ...

[1] The mainstay of treatment is oral glucocorticoids (GC), with the recent BSR-BHPR guidelines suggesting an initial prednisone dose comprised between 15 and 20 mg as appropriate. [2] However ...

Conclusion Low-dose MR prednisone added to existing DMARD treatment produced ... in the MR prednisone group (due in one case each to: headache, headache and hypertension, glaucoma, RA flare and ...

Corticosteroids are the standard treatment prescribed in the management of polymyalgia rheumatica (PMR); due to the lack of quality studies, there is, however, a great variability in the initial dose ...

Initially the patient’s prednisolone was increased to 40 mg/day. Later with the clinical diagnosis of cluster headache, she was treated with subcutaneous sumatriptan with good symptom relief and the ...

He was commenced on high-dose oral prednisolone and was managed by ophthalmology and ... This case illustrates how unexplained persistent headaches should raise the index of suspicion of atypical ...

Our results support the hypothesis that a low initial dose of prednisone is sufficient to control PMR in the majority of patients. They also suggest that 0.20 mg per kg weight could be the ...

Four outpatients not receiving corticosteroids were given oral prednisone at dose of 1.5 mg/kg of body weight per day ... In the remaining patients the observed adverse effects were headache and ...

A prednisone taper gradually reduces your corticosteroid dose over days, weeks, or months to prevent prednisone withdrawal. Stopping prednisone abruptly can lead to adrenal insufficiency ...

While a prior study showed that 5 mg of prednisolone daily was safe, the effects of a 2.5 mg dose have not been explored. Researchers conducted a prospective study to assess the safety and QoL impact ...

Proximal muscle pain disappeared within 8 weeks, on average, and the Health Assessment Questionnaire-Disability Index scores (p=0.098) and concomitant prednisolone doses (p<0.05) decreased at 12 weeks ...

Objective: To test, in a randomised double-blind placebo-controlled crossover trial, the hypothesis that a small short-term increase in the dose of prednisolone will reduce the release of cytokines ...